A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Recruiting now · Phase 2
Conditions studied: Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn's Disease
In brief
This is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis). The primary goal of this study is to assess the safety and efficacy of multiple investigational drugs.
Key facts
- Study ID
- NCT07113522
- Run by
- Mirador Therapeutics, Inc.
- People needed
- 140
- Starts
- 2025-06-26
- Expected to finish
- 2028-02-04
- Last updated by the study team
- 2026-03-12
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mirador Therapeutics Selected Site — Scottsdale, Arizona, United States (enrolling)
- Mirador Therapeutics Selected Site — Sun City, Arizona, United States (enrolling)
- Mirador Therapeutics Selected Site — Little Rock, Arkansas, United States (enrolling)
- Mirador Therapeutics Selected Site — Little Rock, Arkansas, United States (enrolling)
- Mirador Therapeutics Selected Site — Colorado Springs, Colorado, United States (enrolling)
- Mirador Therapeutics Selected Site — Littleton, Colorado, United States (enrolling)
- Mirador Therapeutics Selected Site — Miami, Florida, United States (enrolling)
- Mirador Therapeutics Selected Site — Miami, Florida, United States (enrolling)
- Mirador Therapeutics Selected Site — Miami, Florida, United States (enrolling)
- Mirador Therapeutics Selected Site — Orlando, Florida, United States (enrolling)
- Mirador Therapeutics Selected Site — Palmetto Bay, Florida, United States (enrolling)
- Mirador Therapeutics Selected Site — Pensacola, Florida, United States (enrolling)
- Mirador Therapeutics Selected Site — Atlanta, Georgia, United States (enrolling)
- Mirador Therapeutics Selected Site — Snellville, Georgia, United States (enrolling)
- Mirador Therapeutics Selected Site — Glenview, Illinois, United States (enrolling)
- Mirador Therapeutics Selected Site — Gurnee, Illinois, United States (enrolling)
- Mirador Therapeutics Selected Site — Lafayette, Louisiana, United States (enrolling)
- Mirador Therapeutics Selected Site — Marrero, Louisiana, United States (enrolling)
- Mirador Therapeutics Selected Site — Shreveport, Louisiana, United States (enrolling)
- Mirador Therapeutics Selected Site — Ypsilanti, Michigan, United States (enrolling)
- Mirador Therapeutics Selected Site — Bridgeton, Missouri, United States (enrolling)
- Mirador Therapeutics Selected Site — Kansas City, Missouri, United States (enrolling)
- Mirador Therapeutics Selected Site — Liberty, Missouri, United States (enrolling)
- Mirador Therapeutics Selected Site — Las Vegas, Nevada, United States (enrolling)
- Mirador Therapeutics Selected Site — Birmingham, Alabama, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.